Learn More
Apexbio Technology LLC GNE-617 hydrochloride 10mg

Supplier: Apexbio Technology LLC B130910
GNE-617 hydrochloride is a small-molecule inhibitor targeting nicotinamide phosphoribosyltransferase (NAMPT) It is designed to inhibit NAMPT thereby disrupting NAD biosynthesis in cells GNE-617 hydrochloride exerts its biological activity primarily by competitively inhibiting the NAMPT substrate leading to decreased intracellular NAD levels In cell-based studies GNE-617 hydrochloride demonstrates nanomolar-range antiproliferative activity in multiple cancer cell lines including glioblastoma (U251) fibrosarcoma (HT1080) prostate carcinoma (PC3) pancreatic adenocarcinoma (MiaPaCa2) and colon carcinoma (HCT116) Based on these pharmacological properties GNE-617 hydrochloride holds research potential in the investigation of NAMPT-dependent cancer biology and therapeutic applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.